Answer
For rheumatoid arthritis, MabThera (rituximab) is contraindicated in patients with severe heart failure (New York Heart Association Class IV) or severe, uncontrolled cardiac disease.
Sources for this answer
- MabThera 100mg and 500mg Concentrate for Solution for InfusionRoche Products Limited · emc · SmPC §4.3 Contraindications · Version 57Document updated
Sources checked